Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lloyd

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 20, 2020
Mortality and Complication Rates in Adult Trauma Patients Receiving Tranexamic Acid: A Single-center Experience in the Post-CRASH-2 EraPablo Joaquin Erramouspe, María Florencia García-Pintos, Simranjeet Benipal, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
Benzopyran sulfonamides as KV1.5 potassium channel blockersJohn Lloyd, Karnail S Atwal, Heather J Finlay, et al.
The New Phytologist|March 24, 2020
Geographic variation in the genetic basis of resistance to leaf rust between locally adapted ecotypes of the biofuel crop switchgrass (Panicum virgatum)Acer VanWallendael, Jason Bonnette, Thomas E Juenger, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agentsZulan Pi, James Sutton, John Lloyd, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonistsHeather J Finlay, Ji Jiang, Yolanda Caringal, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Wayne Vacarro, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonistsJohn Lloyd, Heather J Finlay, Karnail Atwal, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Pseudosaccharin amines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Alexander Kover, et al.
Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 20, 2020
Mortality and Complication Rates in Adult Trauma Patients Receiving Tranexamic Acid: A Single-center Experience in the Post-CRASH-2 EraPablo Joaquin Erramouspe, María Florencia García-Pintos, Simranjeet Benipal, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
Benzopyran sulfonamides as KV1.5 potassium channel blockersJohn Lloyd, Karnail S Atwal, Heather J Finlay, et al.
The New Phytologist|March 24, 2020
Geographic variation in the genetic basis of resistance to leaf rust between locally adapted ecotypes of the biofuel crop switchgrass (Panicum virgatum)Acer VanWallendael, Jason Bonnette, Thomas E Juenger, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agentsZulan Pi, James Sutton, John Lloyd, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonistsHeather J Finlay, Ji Jiang, Yolanda Caringal, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Wayne Vacarro, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonistsJohn Lloyd, Heather J Finlay, Karnail Atwal, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Pseudosaccharin amines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Alexander Kover, et al.
Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.
Pageof 9